Edgewise Therapeutics Inc (EWTX)
19.70
+0.41
(+2.13%)
USD |
NASDAQ |
May 03, 14:23
Edgewise Therapeutics Market Cap: 1.834B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.796B |
| May 01, 2024 | 1.770B |
| April 30, 2024 | 1.670B |
| April 29, 2024 | 1.588B |
| April 26, 2024 | 1.506B |
| April 25, 2024 | 1.484B |
| April 24, 2024 | 1.500B |
| April 23, 2024 | 1.457B |
| April 22, 2024 | 1.404B |
| April 19, 2024 | 1.418B |
| April 18, 2024 | 1.439B |
| April 17, 2024 | 1.457B |
| April 16, 2024 | 1.548B |
| April 15, 2024 | 1.534B |
| April 12, 2024 | 1.524B |
| April 11, 2024 | 1.535B |
| April 10, 2024 | 1.483B |
| April 09, 2024 | 1.507B |
| April 08, 2024 | 1.572B |
| April 05, 2024 | 1.579B |
| April 04, 2024 | 1.538B |
| April 03, 2024 | 1.723B |
| April 02, 2024 | 1.645B |
| April 01, 2024 | 1.678B |
| March 28, 2024 | 1.698B |
| Date | Value |
|---|---|
| March 27, 2024 | 1.672B |
| March 26, 2024 | 1.596B |
| March 25, 2024 | 1.490B |
| March 22, 2024 | 1.513B |
| March 21, 2024 | 1.573B |
| March 20, 2024 | 1.561B |
| March 19, 2024 | 1.507B |
| March 18, 2024 | 1.446B |
| March 15, 2024 | 1.575B |
| March 14, 2024 | 1.589B |
| March 13, 2024 | 1.621B |
| March 12, 2024 | 1.650B |
| March 11, 2024 | 1.560B |
| March 08, 2024 | 1.598B |
| March 07, 2024 | 1.652B |
| March 06, 2024 | 1.583B |
| March 05, 2024 | 1.580B |
| March 04, 2024 | 1.583B |
| March 01, 2024 | 1.554B |
| February 29, 2024 | 1.520B |
| February 28, 2024 | 1.550B |
| February 27, 2024 | 1.569B |
| February 26, 2024 | 1.587B |
| February 23, 2024 | 1.609B |
| February 22, 2024 | 1.617B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
281.09M
Minimum
May 25 2022
1.859B
Maximum
Feb 07 2024
753.79M
Average
613.18M
Median
May 22 2023
Market Cap Benchmarks
| Sarepta Therapeutics Inc | 12.68B |
| PTC Therapeutics Inc | 2.547B |
| Fate Therapeutics Inc | 411.84M |
| Viking Therapeutics Inc | 8.533B |
| Regenxbio Inc | 823.57M |
Market Cap Related Metrics
| Price to Book Value | 5.753 |
| Price | 19.70 |
| Earnings Yield | -8.02% |